John C Martin Sarepta Therapeutics, Inc. (SRPT) insider trading activity

SRPT Quotes by TradingView

John C Martin is Director of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 7,913 shares of SRPT, which is worth approximately $1.02 Million. The most recent transaction as insider was on Mar 03, 2021, when has been sold 2,726 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.91K
0% 3M change
0% 12M change
Total Value Held $1.02 Million

JOHN C MARTIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2021
BUY
Grant, award, or other acquisition
-
2,726 Added 25.62%
7,913 Common Stock

Also insider at

KRON
Kronos Bio, Inc. Healthcare
Director
JCM

John C Martin

Director
Cambridge, MA

Track Institutional and Insider Activities on SRPT

Follow Sarepta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

News

Receive news related to Sarepta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SRPT